Il2m International Corp (ILIM) financial statements (2021 and earlier)

Company profile

Business Address 3500 WEST OLIVE AVENUE
BURBANK, CA 91505
State of Incorp. NV
Fiscal Year End May 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

5/31/2014
5/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments150
Cash and cash equivalents150
Receivables 0
Prepaid expense15
Other current assets32
Other undisclosed current assets(46) 
Total current assets:150
Noncurrent Assets
Property, plant and equipment47 
Other undisclosed noncurrent assets329
Total noncurrent assets:789
TOTAL ASSETS:7959
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:24041
Interest and dividends payable2 
Other undisclosed accounts payable and accrued liabilities23841
Debt1010
Due to related parties27 
Deferred revenue and credits2 
Other undisclosed current liabilities13,092 
Total current liabilities:13,46242
Noncurrent Liabilities
Long-term debt and lease obligation 53
Long-term debt, excluding current maturities 53
Liabilities, other than long-term debt38 
Deferred revenue and credits38 
Total noncurrent liabilities:3853
Total liabilities:13,50094
Stockholders' equity
Stockholders' equity attributable to parent, including:(13,421)(35)
Common stock181
Additional paid in capital4,065253
Accumulated deficit(17,504) 
Other undisclosed stockholders' equity attributable to parent (289)
Total stockholders' equity:(13,421)(35)
TOTAL LIABILITIES AND EQUITY:7959

Income statement (P&L) ($ in thousands)

5/31/2014
5/31/2013
Gross profit: 0
Operating expenses (112)
Operating loss: (112)
Interest and debt expense (0)
Net loss available to common stockholders, diluted: (113)

Comprehensive Income ($ in thousands)

5/31/2014
5/31/2013
Net loss: (113)
Comprehensive loss, net of tax, attributable to parent: (113)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: